Inactief instrument

Andere talen Cosmo Pharmaceuticals S.p.A Swiss Exchange

Aandelen

IT0004167463

slotkoers Swiss Exchange Andere beurzen
- ^CHF	-

26/04	Cosmo Pharmaceuticals N.V. kondigt wijzigingen aan in de raad van bestuur tijdens de komende jaarlijkse algemene vergadering op 24 mei 2024	CI
25/04	Cosmo Pharmaceuticals benoemt nieuwe CEO, voorzitter	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Cosmo Pharmaceuticals N : EGM – 5 July 2024 – Written Proxy	06/06
Cosmo Pharmaceuticals N : EGM – 5 July 2024 – Proposed Amendments to the Renumeration Policy	06/06
Cosmo Pharmaceuticals N : EGM – 5 July 2024 – Notification of number of shares as of 6 June 2024	06/06
Cosmo Pharmaceuticals N : EGM – 5 July 2024 – Explanatory Notes	06/06
Cosmo Pharmaceuticals N : EGM – 5 July 2024 – Convening Notice	06/06
Cosmo Pharmaceuticals N : Written proxy – EGM 5 July 2024	06/06
Cosmo Pharmaceuticals N : Proposed Amendments to the Remuneration Policy – EGM 5 July 2024	06/06
Cosmo Pharmaceuticals N : Notification of number of shares 6 June 2024 – EGM 5 July 2024	06/06
Cosmo Pharmaceuticals N : Explanatory notes – EGM 5 July 2024	06/06
Cosmo Pharmaceuticals N : Convening notice – EGM 5 July 2024	06/06
Morning Briefing - Markt Schweiz	03/06
Cosmo Pharmaceuticals Swings to Loss in FY23; Revenue Down	03/06
Cosmo to Bring Real-Time AI into Intelligent Medical Devices with NVIDIA IGX	03/06
Cosmo Reports Excellent Final Full Year 2023 Financial Results - Increases Operating Profit Guidance for 2024 - Dividend of 2.00 per Share Will Be Proposed at EGM on 5 July 2024	01/06
Cosmo Pharmaceuticals N : reports excellent final Full Year 2023 financial results – Increases operating profit guidance for 2024 – Dividend of € 2.00 per share will be proposed at EGM on 5 July 2024	31/05
Cosmo Pharmaceuticals' Shareholders Approve All Agenda Items at Annual General Meeting	24/05
Cosmo Pharmaceuticals N : ’ Shareholders approve all Agenda Items at Annual General Meeting	24/05
Cosmo Pharmaceuticals N : Niall Donnelly CV	09/05
Cosmo Pharmaceuticals N : Convening notice	09/05
Cosmo Pharmaceuticals N : Written Proxy	09/05

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Cosmo Pharmaceuticals S.p.A Swiss Exchange

Aandelen

IT0004167463

Andere talen

Filters